4.6 Article

Celiac disease arthropathy and autoimmunity study

期刊

出版社

WILEY
DOI: 10.1111/j.1440-1746.2012.07272.x

关键词

celiac disease; gluten free diet; non-celiac disease

向作者/读者索取更多资源

Background and Aim: To evaluate presence of sero-negative spondyloarthritis (SpA) in celiac disease (CD) patients, and whether compliance with a gluten free diet (GFD) improved arthritis manifestations in these patients. Methods: We undertook a prospective, questionnaire based, cross-sectional cohort study to evaluate the presence or absence of SpA simultaneously in both CD and non-CD cohorts. Results: 356/590 (60.3%) patients with CD participated in this study. 99% had diagnosis confirmed by a diagnostic test (79% small bowel biopsy, 19.8% blood test, 3.9% stool test). Approximately 131 (37%) cases of arthritis were reported in CD patients. Of the 6/356 CD patients with seronegative spondyloarthritides, four had sacroiliitis, two ankylosing spondylitis, and one psoriatic arthritis, compared to one ankylosing spondylitis and five psoriatic arthritis in non-CD. Osteoarthritis (89 vs 59, P = 0.93) was the most common diagnosis reported by respondents. More CD patients with diarrhea (94%) and anemia (81%) improved on GFD, compared to arthritis symptoms (30%). Autoimmune thyroiditis (10.6% vs 0.4%), insulin dependent diabetes mellitus (IDDM) (2.2% vs 1.7%), systemic Lupus erythematosus (SLE) (1.1% vs 0), and psoriasis (12.9% vs 5.5%) occurred more frequently in CD patients. The prevalence of Crohn's disease, ulcerative colitis, Sjogren's syndrome, primary biliary cirrhosis, and primary sclerosing cholangitis was around 1% each. Univariate Logistic regression analysis showed <= high school education (odds ratio [OR] 2.01, P < 0.003), age >= 60 years (OR 4.13, P < 0.001), and osteoporosis (OR 2.78, P < 0.001) to be significantly associated with report of arthritis in CD patients. Conclusion: We did not find a high rate of SpA in CD patients. In contrast, increased rates of autoimmune thyroiditis, SLE, IDDM, and psoriasis were seen in CD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Gastroenterology & Hepatology

Letter: faecal microbiota transplantation for IBS

Jonathan P. Segal, Benjamin H. Mullish, Mohammed Nabil Quraishi, Tariq H. Iqbal

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

Article Gastroenterology & Hepatology

Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn's Disease

Jonathan M. Rhodes, Sreedhar Subramanian, Paul K. Flanagan, Graham W. Horgan, Kate Martin, John Mansfield, Miles Parkes, Ailsa Hart, Helen Dallal, Tariq Iqbal, Jeffrey Butterworth, Kate Culshaw, Christopher Probert

Summary: The study assessed the efficacy and safety of an antibiotic/hydroxychloroquine combination for Crohn's disease, finding overall results to be unimpressive but showing long-term remission in some patients, warranting further study.

DIGESTIVE DISEASES AND SCIENCES (2021)

Article Gastroenterology & Hepatology

Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic

Gianluca Ianiro, Benjamin H. Mullish, Colleen R. Kelly, Zain Kassam, Ed J. Kuijper, Siew C. Ng, Tariq H. Iqbal, Jessica R. Allegretti, Stefano Bibbo, Harry Sokol, Faming Zhang, Monika Fischer, Samuel Paul Costello, Josbert J. Keller, Luca Masucci, Joffrey van Prehn, Gianluca Quaranta, Mohammed Nabil Quraishi, Jonathan Segal, Dina Kao, Reetta Satokari, Maurizio Sanguinetti, Herbert Tilg, Antonio Gasbarrini, Giovanni Cammarota

Letter Gastroenterology & Hepatology

Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward

Christopher A. Green, Mohammed N. Quraishi, Sahida Shabir, Naveen Sharma, Richard Hansen, Daniel R. Gaya, Ailsa L. Hart, Nicholas J. Loman, Tariq H. Iqbal

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Editorial Material Gastroenterology & Hepatology

Precision Medicine with FMT for Ulcerative Colitis: Are We There Yet?

Mohammed Nabil Quraishi, Tariq H. Iqbal, Ailsa L. Hart

JOURNAL OF CROHNS & COLITIS (2021)

Review Gastroenterology & Hepatology

SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement

James L. Alexander, Gordon W. Moran, Daniel R. Gaya, Tim Raine, Ailsa Hart, Nicholas A. Kennedy, James O. Lindsay, Jonathan MacDonald, Jonathan P. Segal, Shaji Sebastian, Christian P. Selinger, Miles Parkes, Philip J. Smith, Anjan Dhar, Sreedhar Subramanian, Ramesh Arasaradnam, Christopher A. Lamb, Tariq Ahmad, Charlie W. Lees, Liz Dobson, Ruth Wakeman, Tariq H. Iqbal, Ian Arnott, Nick Powell

Summary: SARS-CoV-2 vaccination in patients with IBD is supported due to anticipated low risks, despite some concerns that protective immune responses may be diminished in certain patients. Further research is needed to address vaccine hesitancy, the impact of immunosuppression, and the search for predictive biomarkers of vaccine success.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Letter Pediatrics

Next-generation sequencing as a clinical laboratory tool for describing different microbiotas: an urgent need for future paediatric practice

Richard Hansen, Mona Bajaj-Elliott, Georgina L. Hold, Konstantinos Gerasimidis, Tariq H. Iqbal, Gregory Amos, Linda Thomas, Julian R. Marchesi

ARCHIVES OF DISEASE IN CHILDHOOD (2021)

Article Gastroenterology & Hepatology

Romanian National Guideline on Translating Fecal Microbiota Transplantation Applications related to Clostridioides difficile Infections into the Local Clinical Practice

Georgiana Emmanuela Gilca-Blanariu, Gabriela Stefanescu, Irina Girleanu, Tariq Iqbal, Jonathan Segal, Benjamin Mullish, Mohammed Nabil Quraishi, Josbert Keller, Tamas Molnar, Francis Megraud, Dan Dumitrascu, Mircea Manuc, Luminita Smaranda Iancu, Cristina Marica, Cristian Gheorghe, Susan Manzoor, Anca Trifan

Summary: Fecal microbiota transplantation involves transferring intestinal microorganisms from a healthy individual to a diseased individual in order to restore normal gut flora. Currently, the only well-supported indication for fecal transplants is for refractory recurrent Clostridioides difficile infection. Regulations regarding fecal transplants vary among different countries, and Romania lacks a national guideline, necessitating the development of a national guideline for fecal microbiota transplantation.

JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2021)

Article Gastroenterology & Hepatology

Faecal microbiota transplantation for recurrent C. difficile infections: challenges and improvement opportunities for clinical practice and healthcare systems

Lucy Hocking, Gianluca Ianiro, Rupert W. Leong, Tariq Iqbal, Dina Kao, Mark Cabling, Stephanie Stockwell, Robert J. Romanelli, Sonja Marjanovic

Summary: This study explores the key components of faecal microbiota transplantation (FMT) provision for recurrent Clostridioides difficile infection (CDI) and highlights the challenges and improvement opportunities in healthcare capacity, donors and donations, patient access, regulation, costs, and reimbursement. The findings emphasize the importance of building appropriate FMT capacity to effectively bring FMT to patients in healthcare systems.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Letter Gastroenterology & Hepatology

SARS-CoV-2 vaccines and donor recruitment for FMT

Gianluca Ianiro, Benjamin H. Mullish, Christian Lodberg Hvas, Jonathan P. Segal, Ed J. Kuijper, Samuel P. Costello, Colleen R. Kelly, Jessica R. Allegretti, Monika Fischer, Tariq H. Iqbal, Reetta Satokari, Dina Kao, Joffrey van Prehn, Siew C. Ng, Stefano Bibbo, Simon Mark Dahl Baunwall, Mohammed N. Quraishi, Harry Sokol, Faming Zhang, Josbert Keller, Luca Masucci, Gianluca Quaranta, Zain Kassam, Maurizio Sanguinetti, Herbert Tilg, Antonio Gasbarrini, Giovanni Cammarota

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

The gut microbiome: what every gastroenterologist needs to know

Benjamin H. Mullish, Mohammed Nabil Quraishi, Jonathan P. Segal, Gianluca Ianiro, Tariq H. Iqbal

Summary: In recent years, there has been a rapid growth in interest in the gut microbiome, especially in its potential contribution to gastrointestinal and liver diseases. This field holds the potential for novel diagnostics and therapeutics, but there are still many uncertainties and areas of debate due to its nascent nature.

FRONTLINE GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemic

Nicholas A. Kennedy, Richard Hansen, Lisa Younge, Joel Mawdsley, R. Mark Beattie, Shahida Din, Christopher A. Lamb, Philip J. Smith, Christian Selinger, Jimmy Limdi, Tariq H. Iqbal, Alan Lobo, Rachel Cooney, Oliver Brain, Daniel R. Gaya, Charles Murray, Richard Pollok, Alexandra Kent, Tim Raine, Neeraj Bhala, James O. Lindsay, Peter M. Irving, Charlie W. Lees, Shaji Sebastian

FRONTLINE GASTROENTEROLOGY (2020)

Review Gastroenterology & Hepatology

Mechanisms underpinning the efficacy of faecal microbiota transplantation in treating gastrointestinal disease

Jonathan P. Segal, Benjamin H. Mullish, Mohammed N. Quraishi, Tariq Iqbal, Julian R. Marchesi, Harry Sokol

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2020)

Review Medicine, General & Internal

Interventions for treating iron deficiency anaemia in inflammatory bowel disease

Morris Gordon, Vassiliki Sinopoulou, Zipporah Iheozor-Ejiofor, Tariq Iqbal, Patrick Allen, Sami Hoque, Jaina Engineer, Anthony K. Akobeng

Summary: Inflammatory bowel disease affects approximately seven million people globally, with up to 90% of patients experiencing iron deficiency anaemia. The optimal treatment for this common systemic manifestation remains unclear among physicians. Studies evaluating the efficacy and safety of different interventions have yielded conflicting results, indicating the need for further research in this area.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)

Article Medicine, General & Internal

Results from the first English stool bank using faecal microbiota transplant as a medicinal product for the treatment of Clostridioides difficile infection

V. L. McCune, M. N. Quraishi, S. Manzoor, C. E. Moran, K. Banavathi, H. Steed, D. C. O. Massey, G. R. Trafford, T. H. Iqbal, P. M. Hawkey

ECLINICALMEDICINE (2020)

暂无数据